Sharepoint Solutions
PRODUCTS
-
Werum PAS-X as a Service delivers a fully managed, cloud-based MES for pharma and biotech, enabling rapid deployment, scalability, cost savings, compliance, and operational efficiency.
-
Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.
-
Expediting the customer journey from discovery all the way through commercial release.
-
As innovation and speed to market become even more critical in the life sciences industry, the safety and efficiency of your facilities matter more than ever.
-
Automated PUPSIT and sterile filtration with enhanced product recovery.
WHITE PAPERS AND CASE STUDIES
-
The Role Of The Technical Transfer Executive Sponsor
Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.
-
The Digital Transformation Of A Leading CDMO's Process Development Lab
Discover how a leading CDMO was able to create a data model for its bioreactors, resulting in easily contextualized data, time savings in manual tasks, and the ability to share insights in real time.
-
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints
A pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Solving Imminent Regulatory Challenges With Single-Use Technologies
Here, we explain how companies using mRNA vaccine technology can address compliance challenges through single-use technologies.
-
A Comprehensive Planning Approach For Cancer Antibody
Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
Gateways To Asia: Market Access In Japan And South Korea
Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.
-
An Introduction To Passive Radar Systems
Dive into the concept and operating principles of passive radar systems, review the basics of bistatic radars, and introduce the concept of emitters of opportunity (EoO) and their ideal qualities.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
IT Changes Implemented To Overcome Future Manufacturing Challenges
Learn how Pfizer and Ferring improved their reporting and batch information management with Rockwell’s technology.
NEWS
-
Spraying Methyl Jasmonate On Fruit Trees Boosts Harvest2/26/2025
Spraying persimmon trees with methyl jasmonate (MeJA) can result in healthier, longer lasting fruit, with increased antioxidants a new Edith Cowan University (ECU) study has found.
-
Global Hydrogen Market: Uniper And thyssenkrupp Uhde Sign Framework Agreement On The Use Of Ammonia Cracking Technology11/26/2025
Uniper and thyssenkrupp Uhde have signed a framework agreement that lays the foundation for the construction of commercial ammonia cracking plants.
-
Touchlight To Supply GMP dbDNA To Support University Of Nottingham's Clinical Study For A Next-Generation Vaccine For Zika Virus8/21/2024
Touchlight, an innovation-driven contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, is proud to announce the clinical supply of its proprietary dbDNA to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
-
NOAA Sea Grant Advances Resilient Coastal Communities With $4M In Support1/10/2024
Sea Grant programs across the U.S. are scaling up capacity to support additional hands-on, collaborative engagement to advance the sustainability of coastal and Great Lakes communities.
-
Moderna Receives Project Award Through BARDA's Rapid Response Partnership Vehicle Consortium To Accelerate Development Of mRNA-Based Pandemic Influenza Vaccine7/2/2024
Moderna, Inc. today announced a project award of $176M through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines.